Diffusion Pharmaceuticals (DFFN) Stock: Rocketing On Regulatory Update
Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) is seeing big gains early on in the market this morning, and for good reason. The company announced that it received FDA approval surrounding enrollment in a key clinical trial. Of course, the news excited investors who are sending the stock to the moon. Today, we’ll talk about: The regulatory … Read more